Cargando…

Comparing the efficacy and safety of medications in adults with hypertrophic cardiomyopathy: a systematic review and network meta-analysis

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease. The purpose of this study was to evaluate the efficacy and safety of several medications and recommend better drug treatments for adults with HCM. METHODS: A review of PubMed, Embase, the Cochrane Controlled Regi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mi, Keying, Wu, Sijia, Lv, Chanyuan, Meng, Yongkang, Yin, Wenchao, Li, Hongkai, Li, Jiangbing, Yuan, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461399/ https://www.ncbi.nlm.nih.gov/pubmed/37645523 http://dx.doi.org/10.3389/fcvm.2023.1190181

Ejemplares similares

Clinical Efficacy and Safety of Cox-Maze IV Procedure for Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy
por: Meng, Yanhai, et al.
Publicado: (2021)

COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021)

Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment
por: Cheng, Zeyi, et al.
Publicado: (2021)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

Model Embraced Electromechanical Coupling Time for Estimation of Heart Failure in Patients With Hypertrophic Cardiomyopathy
por: Hu, Su, et al.
Publicado: (2022)

Anxiety Predicts Poor Prognosis in Patients With Hypertrophic Cardiomyopathy
por: He, Chao-Jie, et al.
Publicado: (2022)

Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy
por: Burkart, Valentin, et al.
Publicado: (2022)

Cardiovascular Imaging in Pregnancy: Valvulopathy, Hypertrophic Cardiomyopathy, and Aortopathy
por: Ismail, Haneen, et al.
Publicado: (2022)

Hypertrophic Obstructive Cardiomyopathy: Comparison of Outcomes After Myectomy or Alcohol Ablation
por: Meng, Xiangbin, et al.
Publicado: (2022)

Body composition and mortality in a cohort study of Chinese patients with hypertrophic cardiomyopathy
por: Zhou, Ke, et al.
Publicado: (2023)

Evaluation of the relationship between left atrial strain and exercise tolerance in patients with hypertrophic cardiomyopathy by treadmill stress echocardiography
por: Su, Ye, et al.
Publicado: (2023)

Non-pharmaceutical Interventions for Hypertrophic Cardiomyopathy: A Mini Review
por: He, Miaomiao, et al.
Publicado: (2021)

Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era
por: Butzner, Michael, et al.
Publicado: (2022)

Further Considerations in Childhood-Onset Hypertrophic Cardiomyopathy Genetic Testing
por: Monasky, Michelle M., et al.
Publicado: (2021)

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2022)

Significance and Determinants of Plasma Apelin in Patients With Obstructive Hypertrophic Cardiomyopathy
por: Yang, Chengzhi, et al.
Publicado: (2022)

Case report: Metastatic melanoma masquerading as apical hypertrophic cardiomyopathy
por: Ashraf, Muddasir, et al.
Publicado: (2022)

Advanced searching for hypertrophic cardiomyopathy heritability in real practice tomorrow
por: Chumakova, Olga S., et al.
Publicado: (2023)

Twenty-four hour variability of inverted T-waves in patients with apical hypertrophic cardiomyopathy
por: Ma, Fei, et al.
Publicado: (2022)

Evaluation of Exercise Tolerance in Non-obstructive Hypertrophic Cardiomyopathy With Myocardial Work and Peak Strain Dispersion by Speckle-Tracking Echocardiography
por: Su, Ye, et al.
Publicado: (2022)

Ventricular Arrhythmia in Septal and Apical Hypertrophic Cardiomyopathy: The French-Canadian Experience
por: Steinberg, Christian, et al.
Publicado: (2020)

Thoracoscopic Trans-mitral Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy in the Elderly
por: Wei, Peijian, et al.
Publicado: (2022)

Basic science methods for the characterization of variants of uncertain significance in hypertrophic cardiomyopathy
por: Doh, Chang Yoon, et al.
Publicado: (2023)

Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance
por: Izquierdo, Cristian, et al.
Publicado: (2021)

Global research trends of hypertrophic cardiomyopathy from 2000 to 2022: Insights from bibliometric analysis
por: Zheng, Xifeng, et al.
Publicado: (2023)

Sex-Related Differences in Protein Expression in Sarcomere Mutation-Positive Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

Derivation and Validation of a Screening Model for Hypertrophic Cardiomyopathy Based on Electrocardiogram Features
por: Guo, Lanyan, et al.
Publicado: (2022)

Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
por: Shen, Hua, et al.
Publicado: (2022)

Tale of two hearts: a TNNT2 hypertrophic cardiomyopathy case report
por: Pham, Justin H., et al.
Publicado: (2023)

Temporal trends of hypertrophic cardiomyopathy in Denmark: a nationwide retrospective cohort study
por: Zörner, Christopher Ryan, et al.
Publicado: (2023)

Risk Factors of Pulmonary Arterial Hypertension and Its Relationship With Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy
por: Nie, Changrong, et al.
Publicado: (2021)

Global Circumferential Strain by Cardiac Magnetic Resonance Tissue Tracking Associated With Ventricular Arrhythmias in Hypertrophic Cardiomyopathy Patients
por: Pu, Cailing, et al.
Publicado: (2021)

A novel compound heterozygous variant in ALPK3 induced hypertrophic cardiomyopathy: a case report
por: Li, Tiange, et al.
Publicado: (2023)

The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease
por: Liu, Shengliang, et al.
Publicado: (2022)

Incremental Values of T1 Mapping in the Prediction of Sudden Cardiac Death Risk in Hypertrophic Cardiomyopathy: A Comparison With Two Guidelines
por: Qin, Le, et al.
Publicado: (2021)

Different phenotype of left atrial function impairment in patients with hypertrophic cardiomyopathy and hypertension: comparison of healthy controls
por: Li, Hongwen, et al.
Publicado: (2023)

First-in-man application of Liwen RF™ ablation system in the treatment of drug-resistant hypertrophic obstructive cardiomyopathy
por: Wang, Zihao, et al.
Publicado: (2022)

Midterm Outcome After Septal Myectomy and Medical Therapy in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy
por: Sun, Jiejun, et al.
Publicado: (2022)

Deep Learning Analysis of Echocardiographic Images to Predict Positive Genotype in Patients With Hypertrophic Cardiomyopathy
por: Morita, Sae X., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0k6tiudedcdak2bbl8lgfba062